Cargando…
SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer
Currently, chemotherapy with platinum-based drugs including cisplatin is the most effective therapy for the treatment of non-small cell lung carcinoma (NSCLC). However, the efficacy of chemotherapy is limited due to commonly developed drug resistance. Spindle and kinetochore-associated complex subun...
Autores principales: | SHEN, LIHUA, YANG, MIN, LIN, QIONGHUA, ZHANG, ZHONGWEI, MIAO, CHANGHONG, ZHU, BIAO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811391/ https://www.ncbi.nlm.nih.gov/pubmed/26985856 http://dx.doi.org/10.3892/or.2016.4670 |
Ejemplares similares
-
SKA3 promotes lung adenocarcinoma metastasis through the EGFR–PI3K–Akt axis
por: Hu, Dan-dan, et al.
Publicado: (2020) -
The SKA and its Computing Challenges
por: Deegan, Miles
Publicado: (2018) -
Aurora B is no Ska fan
por: Leslie, Mitch
Publicado: (2012) -
MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas
por: Fadejeva, Irina, et al.
Publicado: (2017) -
Forecasting Sales at Ska Brewing Company
por: Drake, Matthew
Publicado: (2014)